Human Cytidine Deaminase: Understanding the Catalytic Mechanism

  title={Human Cytidine Deaminase: Understanding the Catalytic Mechanism},
  author={Stefano Costanzi and Silvia Vincenzetti and Alberto Vita and Catia Lambertucci and Sara Taffi and Rosaria Volpini and Sauro Vittori and Gloria Cristalli},
  journal={Nucleosides, Nucleotides \& Nucleic Acids},
  pages={1539 - 1543}
Abstract In the absence of an experimentally elucidated three-dimensional structure of the human CDA, we built an homology model of this enzyme starting from the crystal structure of its E. coli homologous. Furthermore, we docked in the active site alternatively the substrate, the intermediate or the product. By means of molecular dynamics simulations, we determined the topology of the active site, identifying the amino acids involved in the catalytic mechanism, and outlining the central role… 
The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?
Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.
Nine novel variants from a pool of 1.6 × 106 transformants that conferred significant zebularine resistance relative to wild-type hCDA2 are identified and are candidates for further exploration for gene-modified HSC transplantation approaches.
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism.
  • E. Sugiyama, N. Kaniwa, N. Saijo
  • Biology, Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007
Haplotype *3 harboring a nonsynonymous SNP, 208G>A (Ala70Thr), decreased clearance of gemcitabine, and increased incidences of neutropenia when patients were coadministered platinum-containing drugs or fluorouracil, cisplatin, or carboplatin.
The effect of genetic variability on drug response in conventional breast cancer treatment.
The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery.
  • T. Watanabe, S. Morinaga, Y. Miyagi
  • Medicine, Biology
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2012
Rôle de la cytidine désaminase dans le contrôle du métabolisme énergétique tumoral pancréatique
La cytidine desaminase (CDA) est surexprimee dans les cancers du pancreas par rapport au tissu sain, and qu'elle est un marqueur de plus mauvais pronostic.


Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex.
The differences in zinc ligands, ligand-binding stereochemistry, and tertiary structures of CDA and ADA strongly suggest that the common features of transition state stabilization arose by convergent evolution.
Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution.
The first structure of a T-CDA from Bacillus subtilis is determined and reveals that the negative charge caused by the three ligands is partly neutralized by an arginine residue hydrogen-bonded to two of the cysteine residues and the dipoles of two alpha-helices.
Identification of four amino acid residues essential for catalysis in human cytidine deaminase by site-directed mutagenesis and chemical modifications.
Kinetic measurements with the specific carboxylic group reagent N-ethoxy-carbonyl-2-eth oxygen-1,2-dihydroquinoline performed on wild-type CDA suggest that Glu67 is essential for the catalytic process, and it seems plausible that the limiting step for the maintenance of zinc in the active site is the formation of coordination between Cys99 and Cys102.
The structure of the cytidine deaminase-product complex provides evidence for efficient proton transfer and ground-state destabilization.
Crystal structures of the cytidine deaminase-uridine product complex prepared either by cocrystallizing enzyme with uridine or by diffusing cytidine into ligand-free crystals show that the product binds as a 4-ketopyrimidine, consistent with the previous proposal that this bond buffers the zinc bond valence, compensating buildup of negative charge on the oxygen nucleophile during catalysis.
Cytidine deaminase complexed to 3-deazacytidine: a "valence buffer" in zinc enzyme catalysis.
The cytidine deaminase substrate analog inhibitor 3-deazacytidine binds with its 4-amino group inserted into a site previously identified as a probable binding site for the leaving ammonia group.
Recombinant human cytidine deaminase: expression, purification, and characterization.
The recombinant CDA has been purified to homogeneity by a rapid procedure consisting of heat inactivation followed by affinity chromatography and showed a specific activity of 105 U/mg, corresponding to about 88-fold purification with respect to the crude extract and was judged to be >98% pure by SDS-PAGE.
A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules
We present the derivation of a new molecular mechanical force field for simulating the structures, conformational energies, and interaction energies of proteins, nucleic acids, and many related
Figure 2. Human CDA catalytic mechanism
    Molecular Biology, submitted
    • J. Mol. Biol
    • 1994